ZYGOGEN, LLC

Company Information
Address 58 Edgewood Avenue
1st Floor, Room 122
ATLANTA, GA, 30303


Information

DUNS: 28796170

# of Employees: N/A


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Compound Screening in Z-Tag Zebrafish Angiogenesis Assay

    Amount: $1,385,560.00

    DESCRIPTION (provided by applicant): Pathological angiogenesis, the growth of new blood vessels during a disease state, contributes to over 70 diseases, including cancer. The proposed studies are a Ph ...

    SBIRPhase II2008Department of Health and Human Services
  2. Z-Tag for Measuring Cardiac Contractility and Cardiac Rhythmicity

    Amount: $153,994.00

    DESCRIPTION (provided by applicant): A major concern regarding drugs in development is cardiac toxicity. Commonly, drugs in development can cause changes to cardiac contractility, the force with which ...

    SBIRPhase I2007Department of Health and Human Services
  3. Zebrafish Tauopathy Model for Drug Screening and Target Validation

    Amount: $153,320.00

    DESCRIPTION (provided by applicant): Description: Several neurological disorders, including Alzheimer's disease and frontotemporal dementia with parkinsonism (FTDP) are characterized in part by neurof ...

    SBIRPhase I2006Department of Health and Human Services
  4. Zebrafish Assay for Parkinson's Disease Drugs

    Amount: $161,135.00

    DESCRIPTION (provided by applicant): Description: The goal of this research program is to develop a rapid, in vivo assay for screening small molecules for their ability to protect or regenerate neuron ...

    SBIRPhase I2006Department of Health and Human Services
  5. Compound Screening in Z-Tag Zebrafish Angiogenesis Assay

    Amount: $163,730.00

    DESCRIPTION (provided by applicant): The purpose of this Phase I proposal is to automate the analysis of the Z-Tag angiogenesis assay and to screen a small collection of compounds for their potential ...

    SBIRPhase I2006Department of Health and Human Services
  6. Zebrafish Screen for Drug-Induced Long QT & Cyp3A

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Many therapeutic drugs have been withdrawn from market because they were found to cause Torsade de Pointes (TdP), a rare cardiac arrhythmia that often results in ...

    SBIRPhase I2005Department of Health and Human Services
  7. Zebrafish Lipid Metabolism Assay for Drug Screening

    Amount: $1,947,220.00

    DESCRIPTION (provided by applicant): Cardiovascular disease is the number one cause of death in the United States today. High levels of cholesterol and triglycerides have been identified as major cont ...

    SBIRPhase II2004Department of Health and Human Services
  8. Zebrafish Assay for Cholesterol and Lipid Lowering Drugs

    Amount: $186,760.00

    DESCRIPTION (provided by applicant): High levels of low density lipoprotein (LDL), cholesterol and triglycerides have been associated with an increase in cardiovascular disease. Drugs such as choleste ...

    SBIRPhase I2003Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government